RELATED CONTENT
NEWS
- US FDA readies to put fingerprints on mobile medical apps, reveals draft guidelines
- US regulators unveil plan to transform FDA to global agency
- UK govt offers "step change" in support for regenerative medicine
- 2011 US submission for Genentech/Curis' vismodegib in basal cell carcinoma

